28782-45-8

Basic information

• Product Name: 1H-Imidazole-5-acetic acid ethyl ester
• Synonyms: 1H-Imidazole-5-acetic acid ethyl ester
• CAS NO: 28782-45-8
• Molecular Weight: 154.169
• Mol File: 28782-45-8.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 1H-Imidazole-5-acetic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Imidazole-5-acetic acid ethyl ester(28782-45-8)
• EPA Substance Registry System: 1H-Imidazole-5-acetic acid ethyl ester(28782-45-8)

Safety Data

• Hazardous Substances Data: 28782-45-8(Hazardous Substances Data)

Usage

Type of compound

chemical compound

Common uses

synthesis of pharmaceutical drugs, reagent in organic chemistry

Properties

ester derivative of imidazole-5-acetic acid, key intermediate in the synthesis of various bioactive compounds

Potential applications

treatment of various diseases (cancer, inflammation, neurological disorders)

Uses in research and development

solvent or reagent in the synthesis of other compounds

Industrial applications

ability to catalyze certain chemical reactions, compatibility with various solvents and reaction conditions.

Upstream product

• 64-17-5 ethanol 
• 645-65-8 2-(1H-imidazol-4-yl)acetic acid 
• 3251-69-2 imidazole-4-acetic acid hydrochloride 
• 288-32-4 1H-imidazole 
• 623-73-4 diazoacetic acid ethyl ester 

Downstream Products

• 884871-53-8 2-(1-benzyloxymethyl-1H-imidazol-4-yl)-2-methylpropionic acid ethyl ester 
• 163210-50-2 ethyl (N-Benzylimidazol-4-yl)acetate 
• 1334540-99-6 ethyl [1-(trans-4-methylcyclohexyl)-1H-imidazol-4-yl]acetate 
• 127607-62-9 1-triphenylmethyl-4-(2-hydroxyethyl)-1H-imidazole 
• 937055-91-9 Ethyl 2-(1-{2-[(4R,6S)-8-chloro-6-(2,3-dimethoxyphenyl)-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl]ethyl}-1H-imidazol-4-yl)acetate 
• 128870-23-5 5'-O--5-<3-<<2-<<<1--1H-imidazol-4-yl>acetyl>amino>ethyl>amino>-3-oxopropyl>-2'-deoxyuridine 
• 128870-19-9 N-(2-Aminoethyl)-1--1H-imidazole-4-acetamide 
• 884871-58-3 2-[1-benzyloxymethyl-2-bromo-5-(2,2-dimethyl[1,3]dioxolan-4-ylmethyl)-1H-imidazol-4-yl]-2-methylpropionic acid ethyl ester 
• 884871-57-2 2-[1-benzyloxymethyl-5-(2,2-dimethyl[1,3]dioxolan-4-ylmethyl)-1H-imidazol-4-yl]-2-methylpropionic acid ethyl ester 
• 884871-72-1 2-[1-benzyloxymethyl-5-(2,3-dihydroxy-propyl)-1H-imidazol-4-yl]-2-methyl-propionic acid ethyl ester 

Relevant articles and documents

NOVEL OXADIAZOLE COMPOUNDS CONTAINING 5- MEMBERED HETEROAROMATIC RING FOR CONTROLLING OR PREVENTING PHYTOPATHOGENIC FUNGI

The present invention relates to a compound of formula (I), wherein, R1,A, A5, A6, A7, A8, R12, n and Q are as defined in the detailed description and a process for preparing the compound of formula (I).The present invention also relates to a method for controlling or preventing phytopathogenic fungi.

RADIOACTIVE HALOGEN LABELED COMPOUNDS OR SALTS THEREOF, AND PHARMACEUTICALS CONTAINING THE SAME

PROBLEM TO BE SOLVED: To provide radioactive halogen labeled compounds which have high selectivity for CYP11B2 over CYP11B1 and accumulation selectivity in the adrenal gland compared to the surrounding organs. SOLUTION: The present invention provides radi

UROCANIC ACID DERIVATIVES USEFUL FOR THE TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES

The invention relates to derivatives of urocanic acid that have improved efficacy and/or tissue penetration properties. The invention further provides use of these derivatives in a medicament for modulating an immune-related disease in an individual. Imidazole derivative, or a salt thereof, selected from O Il W-C-Rl H- (formula 1); o Il W-C-Rl and HN N r 1 NH (formula 2); O O Ov ^W-C-Rl and HN N (formula 3);